What You Need to Know About the ADA Scientific Sessions with Breakthrough T1D CEO Aaron Kowalski
in Research
On T
hursday, July 7 at 6:00 PM ET join Breakthrough T1D CEO Aaron Kowalski, Ph.D. for an overview of the biggest research news from the American Diabetes Association 82nd Scientific Sessions. The Scientific Sessions is arguably the biggest diabetes meeting in the world, where over 120 researchers funded by Breakthrough T1D currently or in the past presented. Dr. Kowalski covers the highlights – many of which were made possible by Breakthrough T1D.
